Secondary PREVENTion of schizophrenia: a controlled study
This study is not recruiting in Germany. It focuses on schizophrenia.
In GermanyThis study is directly about Schizophrenia.

Compare studies and check their requirements with the research team.
This study is not recruiting in Germany. It focuses on schizophrenia.
In GermanyThis study is directly about Schizophrenia.
This study is looking at whether a digital support tool can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
In United KingdomThis study is directly about Schizophrenia.
This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
In ChinaThis study is directly about Schizophrenia.
This study is looking at a support or therapy approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in the program or support approach and complete follow-up assessments.
In PolandThis study is directly about Schizophrenia.
This study is not recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is directly about Schizophrenia.
This study is looking at whether The researchers use a completely random method for grouping can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
In ChinaThis study is directly about Schizophrenia.
This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in a digital support tool and complete follow-up assessments.
In SpainThis study is directly about Schizophrenia.
This study is looking at whether a digital support tool can help people with Amelioration of cognitive deficit in schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in a digital support tool and complete follow-up assessments.
In Czech RepublicThis study is directly about Schizophrenia.
This study is looking at whether TOCTAP is a randomised, three-armed double-blind study with 60 patients suffering from schizophrenia, using DSM-IV diagnostic criteria can help people with Schizophrenia, cognitive functions, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
In GermanyThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In United KingdomThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In FinlandThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In United KingdomThis study is directly about Schizophrenia.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.